Yearly zoledronic acid in postmenopausal osteoporosis

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 357; no. 7; p. 712
Main Authors Karam, Roger, Camm, John, McClung, Michael
Format Journal Article
LanguageEnglish
Published United States 16.08.2007
Subjects
Administration, Oral
Aged
Alendronate - adverse effects
Atrial Fibrillation - chemically induced
Bone Density Conservation Agents - administration & dosage
Bone Density Conservation Agents - adverse effects
Diphosphonates - administration & dosage
Diphosphonates - adverse effects
Etidronic Acid - adverse effects
Etidronic Acid - analogs & derivatives
Female
Fractures, Bone - prevention & control
Humans
Imidazoles - administration & dosage
Imidazoles - adverse effects
Osteoporosis, Postmenopausal - drug therapy
Risedronate Sodium
Online AccessGet full text

Cover

More Information
ISSN:1533-4406